Topical ocular 0.1% cyclosporine A cationic emulsion in dry eye disease patients with severe keratitis: experience through the French early-access program

PURPOSE: The objective of this study was to report the evaluation of efficacy and safety of cyclosporine A cationic emulsion (CsA CE) 0.1% for the treatment of severe keratitis in adults with dry eye disease (DED) in a French early-access program. METHODS: Patients with DED and severe keratitis (cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Pisella, Pierre-Jean, Labetoulle, Marc, Doan, Serge, Cochener-Lamard, Beatrice, Amrane, Mourad, Ismail, Dahlia, Creuzot-Garcher, Catherine, Baudouin, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804729/
https://www.ncbi.nlm.nih.gov/pubmed/29440872
http://dx.doi.org/10.2147/OPTH.S150957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5804729/
https://www.ncbi.nlm.nih.gov/pubmed/29440872
http://dx.doi.org/10.2147/OPTH.S150957

Ejemplares similares